Selected currency: US Dollars.
Change to EUROS
 
Process Validation - Life Cycle Approach
Process Validation - Life Cycle Approach
Process Validation - Life Cycle Approach
Process Validation is the collection and evaluation of data, from the process design stage through commercial production, which establishes scientific evidence that a process is capable of consistently delivering quality product. Grace McNally, FDA, will discuss and review the goals of the 2011 Final Guidance on Process Validation, the various stages of the lifecycle approach and key recommendations, cGMPs and Process Validation (PV) for drug manufacturing, legacy products and process, terminology, as well as the major concerns about the 2008 Draft and response. At the conclusion of this session, participants will be able to:
  • Understand the goals of the 2011 Final Guidance on Process Validation
  • Understand cGMPs and Process Validation (PV) for drug manufacturing
  • Understand the general principles and practices of Process Validation
  • Understand the application of Process Validation guidance through the life cycle approach

  • Who should attend: Production Managers, Bioprocess Engineers, QA and Regulatory Affairs Managers

    Presenter Biography
    Grace McNally,Consumer Safety Officer, FDA, USA is a Senior Policy Advisor in CDER’s Office of Compliance, Division of Manufacturing and Product Quality, Guidance and Policy Team and currently is Acting Branch Chief for Recalls and Drug Shortage within DMPQ. Previously, she served as a Compliance Officer handling domestic CGMP cases. She is active on several Guidance working groups dealing with process validation, combination products and revisions of the CGMPs, as well as developing training for FDA and industry. Prior to coming to CDER she was a field investigator in ORA’s Denver District, specializing in pharmaceutical and medical devices inspections. McNally began her FDA career in Philadelphia District before moving to Colorado to assume the Recall and Complaint Coordinator position in the Denver District. After two years in that capacity she returned to inspectional work in the drug and device arena. She graduated from Boston College, Chestnut Hill, MA.
    Discounted member price: 49.00
    Your price: 149.00
    You could save 67.1%
    Quantity:

    Process Validation is the collection and evaluation of data, from the process design stage through commercial production, which establishes scientific evidence that a process is capable of consistently delivering quality product. Grace McNally, FDA, will discuss and review the goals of the 2011 Final Guidance on Process Validation, the various stages of the lifecycle approach and key recommendations, cGMPs and Process Validation (PV) for drug manufacturing, legacy products and process, terminology, as well as the major concerns about the 2008 Draft and response.

    Member Price: $ 49.00 / € 40.00
    Non Member Price: $ 149.00 / € 110.00
    Item #: WEBPVLIFEUS


    **  New Not a Member?  Join now and get Member Pricing on your purchase!

    Please note: ISPE does not pay customs or duties on international shipping.

    View Our Shipping and Return Policy

    Similar products

    No products found